Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions; pharmaceutical preparations for the treatment of pulmonary disorders such as idiopathic pulmonary fibrosis and acute lung injury; and pharmaceutical preparations for the treatment of cancers and inflammatory disorders